Clinical trials
Pelvic Neoplasm clinical trials
Below are recruiting pelvic neoplasm clinical trials, each written for real people, not researchers. We’re tracking 18 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06915727RecruitingPhase 3
Testing an imaging drug to see tumors in children having surgery
This study tests a special imaging drug called pafolacianine (Cytalux) that helps doctors see tumors more clearly during surgery. It is for children and teens who have a solid tumor in the body and are already scheduled for tumor removal or biopsy.
Rochester, MinnesotaAges 6 months–17 years - NCT05605353Recruiting
Using gut bacteria to study pelvic cancers
This study looks at gut bacteria (and the chemicals they make) in people being treated for pelvic cancers. The goal is to understand what might be happening in the gut and how it could relate to pelvic cancer.
Aberdeen, ScotlandAges 16–99 - NCT06651697RecruitingPhase 3
Full vs empty bladder for pelvic radiation
This trial is comparing two ways to prepare for pelvic radiation therapy: either with a full bladder or an empty bladder. The goal is to see which method works better for protecting healthy organs and reducing side effects.
San Diego, CaliforniaAges 18 years+ - NCT06279299Recruiting
Lymph node removal for rectal neuroendocrine tumors during laparoscopic surgery
This trial tests whether removing lymph nodes in the pelvis during laparoscopic surgery for rectal neuroendocrine tumors (a type of slow-growing or aggressive tumor) improves outcomes. It is for people with larger or recurrent tumors, or those at higher risk due to tumor grade or depth.
Beijing, Beijing MunicipalityAges 18–75 - NCT05134142Recruiting
Quality of life after hemipelvectomy for pelvic tumors
This study looks at how people with pelvic tumors feel and function after a hemipelvectomy (surgery removing part of the hip/pelvis). It aims to better understand recovery and day-to-day quality of life after this operation.
Houston, TexasAges Any age - NCT04949646Recruiting
Nerve monitoring during rectal cancer surgery
This trial studies whether checking pelvic nerve signals during rectal cancer surgery (total mesorectal excision) is helpful. It may help surgeons avoid nerve injury while removing the cancer.
LarissaAges 18–90 - NCT06988280Recruiting
Draining pelvic cysts through the vagina with ultrasound
This trial drains fluid-filled cysts in the pelvis (like ovarian cysts or abscesses) through the vagina using an ultrasound to guide the needle. It aims to relieve pain and symptoms, especially when surgery or cure isn't an option.
Leuven, Vlaams-BrabantAges 18 years+ - NCT03622983Recruiting
Biobank study for pelvic cancers and endometriosis samples
This study collects and stores biological samples (like tissue or other lab samples) from people with pelvic gynecologic cancers or endometriosis, and links them with imaging/radiology information. It may help researchers learn more about these conditions and how they behave over time.
CréteilAges 18 years+ - NCT06803251Recruiting
Vascular surgeon role in removing abdominal or pelvic masses
This study looks at how a vascular surgeon (a blood vessel specialist) can help when removing masses in the back of the abdomen or pelvis. If you have a mass that touches blood vessels and you need surgery, this trial may be a good fit for you.
Bologna, ItaliaAges 18 years+ - NCT02222844Recruiting
MRI checks for treatment planning in sigmoid colon cancer
This study uses MRI scans to better plan “curative” treatment (aimed at cure) for sigmoid colon cancer before surgery. It is for people who may still be deciding on the radical (major, curative) treatment plan and who can safely have an MRI.
Huntingdon, CambridgeshireAges 16 years+ - NCT07234968Recruiting
Stent vs no stent after bladder removal surgery
This study looks at whether leaving a small tube (ureteral stent) in place after bladder removal helps recovery. It compares people who get a stent to those who don't, focusing on problems like leaks or infections after surgery.
Philadelphia, PennsylvaniaAges 18–85 - NCT05457595Recruiting
Re-irradiation for pelvic and groin cancer recurrences
This study tests giving radiation again to treat a cancer that has returned in the pelvic area (including the groin) when surgery isn’t a good option. It may help control the tumor while trying to protect nearby organs such as the small intestine.
Pavia, PvAges 18 years+ - NCT06290687RecruitingPhase 2
Partial cystectomy with chemo for bladder cancer
This trial tests whether removing part of the bladder (partial cystectomy) along with standard chemotherapy or immunotherapy before surgery is effective for people with a specific type of bladder cancer that hasn't spread beyond the bladder.
Cleveland, OhioAges 19 years+ - NCT05610501Recruiting
Ultrasound-guided biopsy for pelvic masses
This study looks at how well an ultrasound-guided needle biopsy (Tru-Cut) can safely collect tissue samples from pelvic masses. It may help doctors confirm diagnoses and guide treatment by improving how biopsies are done in real-world care.
LeuvenAges 18 years+ - NCT06638593Recruiting
Comparing open vs. robotic surgery for pelvic masses up to 8cm
This study compares two types of minimally invasive surgery—traditional laparoscopic (keyhole) versus robotic-assisted—for removing complex ovarian cysts or masses up to 8cm that haven't spread. The goal is to see which approach might offer better recovery and outcomes for women with these growths.
GuildfordAges 18–100 - NCT02292641Recruiting
MRI study for repeat pelvic colorectal cancer
This study uses a special MRI to help understand and stage colorectal cancer that has come back in the pelvis. The goal is to improve how doctors make treatment decisions after previous surgery.
OsloAges 16 years+ - NCT06353906RecruitingPhase 2
Chemo plus immunotherapy for advanced penile cancer
This trial tests a combination of two chemotherapy drugs (carboplatin and paclitaxel) plus the immunotherapy drug pembrolizumab (Keytruda) for penile cancer that has spread to nearby lymph nodes. The goal is to see if this combination can shrink or control the cancer before or after surgery.
LeuvenAges 18 years+ - NCT07483658Recruiting
Salvage pelvic radiotherapy: 20 vs 25 sessions for recurring prostate cancer
This trial compares two schedules of pelvic radiotherapy for men whose prostate cancer has returned after surgery. Both schedules aim to control the cancer with fewer visits for one of them.
Gatineau, QuebecAges 18 years+
Hear when a new Pelvic Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pelvic neoplasm?
- Yes. Clin2 currently lists 18 recruiting pelvic neoplasm studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pelvic neoplasm trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pelvic neoplasm trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.